Skip to main content
Dan Barouch, MD, Infectious Disease, Boston, MA

Dan H Barouch MD

Infectious Disease•Boston, MA

Professor, Medicine, Beth Israel Deaconess Medical Center, Harvard Medical School

Join to View Full Profile

  • 330 Brookline AveResearch East 113 Beth Israel Deaconess HospitalBoston, MA 02215

  • Phone+1 617-667-4434

  • Fax+1 617-667-8210

Dr. Barouch is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Barouch's Full ProfileAlready have an account?

Education & Training

  • Mass General Brigham/Massachusetts General Hospital/Brigham and Women's Hospital
    Mass General Brigham/Massachusetts General Hospital/Brigham and Women's HospitalFellowship, Infectious Disease, 2001 - 2005
  • Harvard Medical School
    Harvard Medical SchoolClass of 2000

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2001 - 2026
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Infectious Disease
    American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Interim Results of a Phase 1–2a Trial of Ad26.COV2.S Covid-19 Vaccine  
    Jerald Sadoff, Kathryn E Stephenson, Dan H Barouch, Macaya Douoguih, The New England Journal of Medicine

Lectures

  • 11th Vaccines Research and Development: All Things Considered Conference 
    Global Technology Community (GTC), Boston, Massachusetts - 7/8/2013
  • Publisher Correction: Antibody and TLR7 Agonist Delay Viral Rebound in SHIV-Infected Monkeys 
    Beth Israel Deaconess Hospital - Needham , Harvard Medical School ,Department Of Continuing Educatio - 5/30/2013

Press Mentions

  • ‘Patients Are Very Sick’: Flu Cases Peaking in Massachusetts, Rest of Country
    ‘Patients Are Very Sick’: Flu Cases Peaking in Massachusetts, Rest of CountryFebruary 26th, 2025
  • CDC Investigating Hospitalizations of Five People Who Recently Received Chikungunya Vaccine
    CDC Investigating Hospitalizations of Five People Who Recently Received Chikungunya VaccineFebruary 26th, 2025
  • Mass. (Un)vaccination: A New Wave of Vaccine Skepticism Threatens Readiness for the Next Pandemic
    Mass. (Un)vaccination: A New Wave of Vaccine Skepticism Threatens Readiness for the Next PandemicFebruary 18th, 2025
  • Join now to see all

Grant Support

  • Multi-Omics Analysis of Broadly Neutralizing Antibodies and Therapeutic VaccinationBETH ISRAEL DEACONESS MEDICAL CENTER2023–2028
  • HIV Vaccines Clinical Trials Network Leadership and Operations CenterFRED HUTCHINSON CANCER CENTER2006–2027
  • I4C 2.0: Immunotherapy for CureBETH ISRAEL DEACONESS MEDICAL CENTER2021–2026
  • Ad26 Based Therapeutic Vaccines for HIVBETH ISRAEL DEACONESS MEDICAL CENTER2020–2026
  • Immunologic Signatures of SARS-CoV-2 Vaccination and DiseaseBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Immunologic Signatures of SARS-CoV-2 Vaccination and DiseaseBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Immunologic Signatures of SARS-CoV-2 Vaccination and DiseaseBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Single-Cell Analysis of the HIV/SIV ReservoirBETH ISRAEL DEACONESS MEDICAL CENTER2020–2025
  • Development of Ad26/Env Vaccines for HIVBETH ISRAEL DEACONESS MEDICAL CENTER2018–2025
  • Consortium For AIDS Vaccine Research In Nonhuman PrimatesNational Institute Of Allergy And Infectious Diseases2011
  • AdministrativeNational Institute Of Allergy And Infectious Diseases2011
  • Adenovirus And Poxvirus Mediated Protection Against Mucosal SIV InfectionNational Institute Of Allergy And Infectious Diseases2011
  • Metagenomics Of Enteric Disease In Siv-Infected And Uninfected MacaquesNational Center For Research Resources2011
  • Impact Of HIV Envelope Conformation On ImmunogenicityNational Institute Of Allergy And Infectious Diseases2009–2011
  • Preclinical Evaluation Of Novel Adenovirus Prime-Boost HIV-1 VaccineNational Institute Of Allergy And Infectious Diseases2008–2011
  • Novel Heterologous Adenovirus Prime-Boost HIV-1 VaccineNational Institute Of Allergy And Infectious Diseases2008–2011
  • Administrative CoreNational Institute Of Allergy And Infectious Diseases2008–2011
  • Novel Recombinant Adenovirus Vaccine Vectors For HIV/SIV In Rhesus MonkeysNational Center For Research Resources2005–2011
  • Novel Adenovirus Vaccine Vectors For HIV/SIVNational Institute Of Allergy And Infectious Diseases2006–2010
  • Preclinical Evaluation Of Novel Adenovirus VectorsNational Institute Of Allergy And Infectious Diseases2005–2009
  • Novel Adenovirus Vector-Based Vaccines For HIV-1National Institute Of Allergy And Infectious Diseases2005–2009
  • Augmentation Of DNA Vaccine-Elicited Immunity To HIV/SIVNational Institute Of Allergy And Infectious Diseases2004–2008
  • AdministrativeNational Institute Of Allergy And Infectious Diseases2005
  • Chimeric Adenovirus Vaccine Vectors For HIV/SIVNational Institute Of Allergy And Infectious Diseases2004–2005
  • Cytokine-Augmented DNA Vaccine-Elicited Immunity To HIVNational Institute Of Allergy And Infectious Diseases2002–2005

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Dan Barouch, Dr. Dan Barouch, MD, Dr. D Barouch, Dr. Dan H Barouch